Pharmafile Logo

Dedicated

Biogen promotes Dr Paul McKenzie

He becomes pharmaceutical operations and technology EVP

Bristol-Myers Squibb (BMS) building

BMS to explore new options for its immuno-oncology drug Opdivo

Partners with PsiOxis to research its use with enadenotucirev

- PMLiVE

Merck & Co signs cancer vaccines research deal for Keytruda

Will work on range of personalised vaccines to complement its blockbuster

- PMLiVE

Ypsomed’s touch screen insulin pump for Novo Nordisk approved by EMA

mylife YpsoPump given green light for use with pump cartridge NovoRapid PumpCart

- PMLiVE

Boehringer Ingelheim launches AI-powered animal health website

The new site uses ‘machine learning’ to tailor content to users’ requirements

- PMLiVE

Dr Keith Bragman joins Alacrita

He becomes a partner at the firm’s London office

- PMLiVE

Tracking comms trends: communication and market access

From multi-disciplinary teamwork to pharma’s reputation, value and access to global briefs, our contributors tackle some of the key topics in communications today

Syneos Health®

Envigo appoints Dr Adrian Hardy as president and CEO

He succeeds Brian Cass in the role

- PMLiVE

Tracking comms trends: communication and market access

From multi-disciplinary teamwork to pharma’s reputation, value and access to global briefs, our contributors tackle some of the key topics in communications today

- PMLiVE

Connected Healthcare

Digital technologies are bringing healthcare professionals (HCPs) and their patients ever closer, and the potential benefits of this type of engagement seem to be many.

- PMLiVE

inVentiv Health wins Pfizer account

Will be tasked with managing the pharma firm’s global clinical services

- PMLiVE

FDA approves Gilead’s ‘universal’ hep C combination Epclusa

Adds a third Sovaldi-based treatment to the firm’s portfolio

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links